Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs

View ORCID ProfileJulian Daniel Sunday Willett, View ORCID ProfileTianyuan Lu, View ORCID ProfileTomoko Nakanishi, View ORCID ProfileSatoshi Yoshiji, View ORCID ProfileGuillaume Butler-Laporte, Sirui Zhou, View ORCID ProfileYossi Farjoun, J. Brent Richards
doi: https://doi.org/10.1101/2023.05.29.23290694
Julian Daniel Sunday Willett
1Centre for Clinical Epidemiology, Department of Medicine, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
2McGill University, Montreal, Quebec, Canada
3Quantitative Life Sciences Program, McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julian Daniel Sunday Willett
Tianyuan Lu
1Centre for Clinical Epidemiology, Department of Medicine, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
2McGill University, Montreal, Quebec, Canada
3Quantitative Life Sciences Program, McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tianyuan Lu
Tomoko Nakanishi
1Centre for Clinical Epidemiology, Department of Medicine, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
2McGill University, Montreal, Quebec, Canada
4Department of Human Genetics, McGill University, Montreal, Quebec, Canada
5Kyoto-McGill International Collaborative Program in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
6Research Fellow, Japan Society for the Promotion of Science, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tomoko Nakanishi
Satoshi Yoshiji
1Centre for Clinical Epidemiology, Department of Medicine, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
2McGill University, Montreal, Quebec, Canada
4Department of Human Genetics, McGill University, Montreal, Quebec, Canada
5Kyoto-McGill International Collaborative Program in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
6Research Fellow, Japan Society for the Promotion of Science, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Satoshi Yoshiji
Guillaume Butler-Laporte
1Centre for Clinical Epidemiology, Department of Medicine, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Guillaume Butler-Laporte
Sirui Zhou
1Centre for Clinical Epidemiology, Department of Medicine, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
2McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yossi Farjoun
1Centre for Clinical Epidemiology, Department of Medicine, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yossi Farjoun
J. Brent Richards
1Centre for Clinical Epidemiology, Department of Medicine, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
2McGill University, Montreal, Quebec, Canada
8Departments of Medicine, Human Genetics, Epidemiology and Biostatistics, McGill University, Montréal, Quebec, Canada
9Department of Twin Research, King’s College London, London, United Kingdom
10Five Prime Sciences Inc, Montréal, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: brent.richards{at}mcgill.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Identifying causal genes at GWAS loci can help pinpoint targets for therapeutic interventions. Expression studies can disentangle such loci but signals from expression quantitative trait loci (eQTLs) often fail to colocalize—which means that the genetic control of measured expression is not shared with the genetic control of disease risk. This may be because gene expression is measured in the wrong cell type, physiological state, or organ. We tested whether Mendelian randomization (MR) could identify genes at loci influencing COVID-19 outcomes and whether the colocalization of genetic control of expression and COVID-19 outcomes was influenced by cell type, cell stimulation, and organ.

We conducted MR of cis-eQTLs from single cell (scRNA-seq) and bulk RNA sequencing. We then tested variables that could influence colocalization, including cell type, cell stimulation, RNA sequencing modality, organ, symptoms of COVID-19, and SARS-CoV-2 status among individuals with symptoms of COVID-19. The outcomes used to test colocalization were COVID-19 severity and susceptibility as assessed in the Host Genetics Initiative release 7.

Most transcripts identified using MR did not colocalize when tested across cell types, cell state and in different organs. Most that did colocalize likely represented false positives due to linkage disequilibrium. In general, colocalization was highly variable and at times inconsistent for the same transcript across cell type, cell stimulation and organ. While we identified factors that influenced colocalization for select transcripts, identifying 33 that mediate COVID-19 outcomes, our study suggests that colocalization of expression with COVID-19 outcomes is partially due to noisy signals even after following quality control and sensitivity testing. These findings illustrate the present difficulty of linking expression transcripts to disease outcomes and the need for skepticism when observing eQTL MR results, even accounting for cell types, stimulation state and different organs.

Author Summary The genetic determinants of disease and gene expression often do not colocalize (which means they do not share a single causal signal). While some researchers have identified factors that could explain this disconnect, such as immune stimulation or tissue studied, understanding of this complex phenomenon remains incomplete. A deeper understanding could help identify additional genes that mediate disease, affording promising targets for treatment or prevention of disease. We used RNA sequencing data collected at the single cell and bulk tissue level to identify genes whose expression influenced COVID-19 outcomes. We assessed which variables influencing colocalization, including cell type, cell stimulation, RNA sequencing modality, organ, symptoms of COVID-19, and SARS-CoV-2 status among individuals with symptoms of COVID-19. We observed that colocalization of specific candidate genes identified by MR was highly variable and influenced by multiple factors, including cell state and cell population. These results illustrate that even after assessing multiple variables that may influence colocalization, there existed few examples of genes identified by MR that colocalized with gene expression. Future studies would benefit from larger transcriptomics study cohorts and more advanced statistical methods which better account for differences in linkage disequilibrium panels between data sources.

Competing Interest Statement

JBR's institution has received investigator-initiated grant funding from Eli Lilly, GlaxoSmithKline and Biogen for projects unrelated to this research. He is the CEO of 5 Prime Sciences (www.5primesciences.com), which provides research services for biotech, pharma and venture capital companies for projects unrelated to this research.

Funding Statement

This work is supported by the CIHR (JDSW CIHR 476575). BQC19 was funded by the Fonds de recherche du Quebec - Sante, Genome Quebec and the Public Health Agency of Canada. The Richards research group is supported by the Canadian Institutes of Health Research (CIHR: 365825; 409511, 100558, 169303), the McGill Interdisciplinary Initiative in Infection and Immunity (MI4), the Lady Davis Institute of the Jewish General Hospital, the Jewish General Hospital Foundation, the Canadian Foundation for Innovation, the NIH Foundation, Cancer Research UK, Genome Quebec, the Public Health Agency of Canada, McGill University, Cancer Research UK [grant number C18281/A29019] and the Fonds de Recherche Quebec Sante (FRQS). JBR is supported by a FRQS Merite Clinical Research Scholarship. Support from Calcul Quebec and Compute Canada is acknowledged. These funding agencies had no role in the design, implementation or interpretation of this study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Soskic et al. biological samples were ethically sourced and used in research under an institutional review board-approved protocol (Soskic et al. 2022). BQC19 received ethical approval from the Jewish General Hospital research ethics board (2020-2137) and the Centre Hospitalier de l'Universite de Montreal institutional ethics board (MP-02-2020-8929, 19.389). Specimens collected by GTEx were sourced per protocol for an institutional review board (GTEx Consortium 2020).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

Data from Soskic et al. are available through Zenodo (doi:10.5281/zenodo.6006796). BQC-19 data, including expression data, is available by application: https://www.bqc19.ca/. GTEx release 8 data is available from: https://www.gtexportal.org/home/. COVID-19 HGI summary statistics are available from: https://www.covid19hg.org/.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted June 01, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs
Julian Daniel Sunday Willett, Tianyuan Lu, Tomoko Nakanishi, Satoshi Yoshiji, Guillaume Butler-Laporte, Sirui Zhou, Yossi Farjoun, J. Brent Richards
medRxiv 2023.05.29.23290694; doi: https://doi.org/10.1101/2023.05.29.23290694
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs
Julian Daniel Sunday Willett, Tianyuan Lu, Tomoko Nakanishi, Satoshi Yoshiji, Guillaume Butler-Laporte, Sirui Zhou, Yossi Farjoun, J. Brent Richards
medRxiv 2023.05.29.23290694; doi: https://doi.org/10.1101/2023.05.29.23290694

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (431)
  • Allergy and Immunology (757)
  • Anesthesia (221)
  • Cardiovascular Medicine (3298)
  • Dentistry and Oral Medicine (365)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1173)
  • Epidemiology (13385)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5158)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3276)
  • Health Policy (1143)
  • Health Systems and Quality Improvement (1193)
  • Hematology (432)
  • HIV/AIDS (1019)
  • Infectious Diseases (except HIV/AIDS) (14637)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (478)
  • Medical Ethics (127)
  • Nephrology (525)
  • Neurology (4930)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (886)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (728)
  • Orthopedics (282)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (544)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4218)
  • Public and Global Health (7512)
  • Radiology and Imaging (1708)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (549)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)